Rockefeller University Press, Journal of Experimental Medicine, 12(215), p. 2967-2968, 2018
DOI: 10.1084/jem.20182069
Full text: Unavailable
In this issue of JEM, Raz et al. (https://doi.org/10.1084/jem.20180818) identify a subset of bone marrow–derived cells that uniquely promotes breast cancer angiogenesis and tumor growth. The existence of functional heterogeneity among stromal populations motivates further fundamental and therapeutic inquiries.